Screening Cancer Readiness Through Education and Empowerment for Newcomer Women
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-70
SponsorErzincan Binali Yildirim Universitesi
About this trial
Purpose: This study was conducted to determine the effect of an online educational intervention on migrant women's knowledge and attitudes toward cancer screening.
DesigN:This study was designed as a two-arm, parallel-group, randomized controlled trial with pre-test and post-test assessments.
Method: The study population will consist of women registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) affiliated with the Erzincan Provincial Health Directorate. The sample size was calculated based on a two-group (intervention and control) and two-measurement (pre-test and post-test) study design. Using repeated-measures ANOVA with a medium effect size (d = 0.25), a significance level of 5% (α = 0.05), and a statistical power of 80% (1 - β = 0.80), the required sample size was determined to be 34 participants per group (34 in the intervention group and 34 in the control group), resulting in a minimum total sample of 68 participants. To account for potential attrition, it was planned to recruit 80 participants (approximately 20% more than the minimum required sample size).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Screening Cancer Readiness through Education and Empowerment for Newcomer Women
Other interventionWomen assigned to the intervention group will be contacted by telephone using the contact information registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM). For participants without a registered telephone number, home visits will be conducted using the addresses recorded in the KETEM database. Following completion of the baseline (pre-test) assessment, participants in the intervention group will receive an online cancer screening education program developed in accordance with the Turkish National Cancer Control Program of the General Directorate of Public Health, Ministry of Health of the Republic of Türkiye. The educational intervention will be delivered in three online sessions via WhatsApp video calls. During each session, participants will have the opportunity to ask questions, which will be answered by the researcher. Prior to each session, reminder text messages will be sent to participants' mobile phones to notify them of the date and time of the schede
Control group
Other interventionWomen assigned to the control group who are registered at the Cancer Early Diagnosis, Screening and Training Center (KETEM) will be contacted and invited to participate in the study. During the initial meeting, written informed consent will be obtained, after which the Personal Information Form and study questionnaires will be administered to collect baseline (pre-test) data. An appointment for the follow-up assessment will be scheduled approximately four weeks later. Five weeks after the baseline assessment, participants will be contacted by telephone to complete the post-test assessment. No educational intervention will be provided to the control group during the study period. After completion of the post-test assessment, participants in the control group will be offered the same cancer screening education program in accordance with the ethical principle of equity.
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: SCREENExperimental treatment 1 intervention
Group B: control groupActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Cancer Screening Knowledge Scale
The Cancer Screening Knowledge Scale is a 25-item questionnaire designed to assess participants' knowledge regarding cancer screening. Total scores range from 0 to 25, with higher scores indicating greater knowledge.
Time frame
From baseline to 5 weeks after baseline2
Cancer Screening Attitude Scale-Short Form
The Cancer Screening Attitude Scale-Short Form is a 15-item questionnaire used to assess participants' attitudes toward cancer screening. Total scores range from 15 to 75, with higher scores indicating more positive attitudes toward cancer screening.
Time frame
From baseline to 5 weeks after baselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: